Anke Hemmerling, MD, PhD, MPH
|Title(s)||Associate Professor, Campuswide Accounting|
|Address||550 16th. Street, #3760|
San Francisco CA 94158
|Humboldt University , Berlin, Germany||MD||06/1999||Medicine|
|Humboldt University , Berlin, Germany||PhD||08/2003||Medical Sciences|
|University of California, Berkeley, Berkeley, California||MPH||05/2004||Public Health|
Anke Hemmerling, MD PhD MPH, is an Associate Adjunct Professor in the UCSF Department of Obstetrics, Gynecology and Reproductive Sciences, and the Director of the Interdisciplinary MPH Program in the UC Berkeley School of Public Health.
She received her medical and public health training at the Humboldt University in Berlin (Germany) and at the University of California, Berkeley (UCB). During her clinical training, she repeatedly worked in health projects and hospitals in Latin America.
Always with a focus on global women’s health, her early career research covered medication abortion, infertility and fertility choices, and safe motherhood.
Her current clinical research is focusing on the prevention of HIV and other genital infections such as bacterial vaginosis in women, conducting a number of clinical trials in the US and South Africa. She served as the protocol co-Chair of the NIH-sponsored multi-site phase 2B study for the prevention of bacterial vaginosis using the live biotherapeutic product LACTIN-V.
At UC San Francisco and UC Berkeley, she is mentoring and teaching several courses for medical students, undergraduate and graduate students, as well as post-doctoral students in several educational programs.
Dr. Hemmerling serves as a senior technical adviser for the Initiative for Multipurpose Prevention Technologies for Reproductive Health (IMPT) and on several data safety monitoring boards for federally funded clinical studies. In addition, she is a member of the Education Committee at the UCGHI Center of Expertise in Women’s Health, Gender and Empowerment.
Areas of Interest:
• Prevention of sexually transmitted infections (STI)
• Drug development: Microbicides and live biotherapeutic products to prevent HIV/STI
• Fertility Choices
• Safe Motherhood
, Drug Development
, Clinical Research
, Global Public Health
, HIV/STI Prevention
, Women's Health and Empowerment
, Innovation in Global Education and Capacity Building
, Interdisciplinary Research Collaboration
, Live Biotherapeutic Products
, Vaginal Microbiome
, Safe Motherhood
, Fertility Choices
With one click, see people who:
See more options in the Advanced Search tab